Trovagene
NASDAQ: CRDFSan Diego, US · Delaware corporation
Biotech
Founders & leadership
TA
Thomas AdamsExecutive
AS
Antonius SchuhNamed on SEC filing
ST
Stanley TennantNamed on SEC filing
DR
David RobbinsNamed on SEC filing
GC
Gabriele CerroneNamed on SEC filing
SZ
Steve ZanibobiNamed on SEC filing
Board
GJ
Gary JacobBoard director
JB
John BrancaccioBoard director
AC
Athena CountouriotisBoard director
RM
Rodney MarkinBoard director
Reported raises · per SEC filings
Form D private placements$35M disclosed across 9 of 10 rounds · 2009–2020
▶$13.5MraisedJun 2020 · 3 investors · BiotechnologyRule 506(b)
▶$13.5MraisedJun 2020 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary JacobDirector
- Mark ErlanderExecutive Officer, Director
- James O. ArmitageDirector
- Lale WhiteDirector
- Thomas AdamsDirector
- Rodney S. MarkinDirector
- John BrancaccioDirector
- Gary W. PaceDirector
- Offering amount
- $13.5M
- Amount sold
- $13.5M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJun 2020 · 1 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary JacobDirector
- Thomas AdamsDirector
- John BrancaccioDirector
- Lale WhiteDirector
- Mark ErlanderExecutive Officer
- Gary W. PaceDirector
- Rodney S. MarkinDirector
- James O. ArmitageDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$810KraisedMay 2020 · 8 investors · BiotechnologyRule 506(b)
▶$810KraisedMay 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas Adams, Ph.D.Director
- Rodney MarkinDirector
- Mark Erlander, Ph.D.Executive Officer
- James ArmitageDirector
- Gary Jacob, Ph.D.Director
- Gary Pace, Ph.D.Director
- John BrancaccioDirector
- Lale WhiteDirector
- Offering amount
- $810K
- Amount sold
- $810K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedApr 2020 · 1 investors · BiotechnologyRule 506(b)
▶$2.1MraisedApr 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rodney S. MarkinDirector
- Mark ErlanderDirector
- Thomas AdamsExecutive Officer, Director
- John BrancaccioDirector
- James O. ArmitageDirector
- Lale WhiteDirector
- Gary W. PaceDirector
- Gary JacobDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedOct 2019 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedOct 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Athena CountouriotisDirector
- Brigitte LindsayExecutive Officer
- Rodney MarkinDirector
- Gary S. JacobDirector
- Thomas H. AdamsExecutive Officer, Director
- John P. BrancaccioDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $1.1M
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedAug 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedAug 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Athena CountouriotisDirector
- John BrancaccioDirector
- Rodney S. MarkinDirector
- Gary JacobDirector
- Thomas AdamsExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMay 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMay 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rodney S. MarkinDirector
- Athena CountouriotisDirector
- Gary JacobDirector
- John BrancaccioDirector
- Thomas AdamsExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedApr 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedApr 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary JacobDirector
- Thomas AdamsExecutive Officer, Director
- John BrancaccioDirector
- Athena CountouriotisDirector
- Rodney S. MarkinDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Trovagene raised?
- Trovagene has disclosed $35M raised across 9 of its 10 known rounds.
- Where is Trovagene headquartered?
- Trovagene is headquartered in San Diego, US.